NCT03416348View on ClinicalTrials.gov

Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2

PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

January 15, 2022

Study Completion Date

February 14, 2022

Conditions
Hyperhidrosis
Interventions
DRUG

Aluminum Chloride 20% (deodorant)

Aluminum Chloride (deodorant)

DRUG

Alcohol

Placebo

Trial Locations (2)

84132-2101

George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

collaborator

U.S. Army Medical Research and Development Command

FED

lead

University of Utah

OTHER

NCT03416348 - Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2 | Biotech Hunter | Biotech Hunter